Diphosphinite AgI and PdII Dinuclear Complexes as Adaptable Anion Receptors: An Unprecedented Bridging Mode for the PF6− Ion

Bridging ligands in Ag(I) and Au(I) bimetallic complexes: The P moiety of bis(2-pyridyl)phosphole acts as a symmetrically, semi-, or non-bridging donor in Ag(I) dimers (see figure). In related Au(I) complexes, only the non-bridging mode is observed. An unsaturated Ag(I) dimer is used as an adaptive molecular clip for the synthesis of pi-stacked metallocyclophanes.Bis(2-pyridyl)phosphole C reacted with AgPF(6) and dppm giving rise to dicationic dimer 1 in which C acts as a 1kappaN:1,2kappaP:2kappaN-donor with a symmetrically bridging P-centre. This complex gives the first example of dimers based on trigonal planar metal centres bearing a bridging sigma(3),lambda(3)-phosphane ligand. The reaction of two equivalents of C with AgPF(6) and Ag{Al[OC(CF(3))(3)](4)} afforded dicationic dimers 2 and 3 of general formula Ag(2)(C)(2) (2+), respectively. X-ray diffraction studies showed that one ligand C acts as a 1kappaN:1,2kappaP:2kappaN-donor with a symmetrically bridging P-centre and one behaves as a 1kappaN:2kappaP-chelate. In complex 3, one toluene molecule interacts with an Ag centre, giving the first example of a mixed coordination dimer featuring a bridging P-donor. Ag(I)-dimers 4 a-c of the general formula Ag(2)(C)(3) (2+), 2 X(-) (X=PF(6), BF(4), Al[OC(CF(3))(3)](4)) have been prepared according to different routes and characterised by X-ray diffraction study. In these derivatives, C exhibits a variety of coordination modes depending on the nature of the counteranion and of the solvent molecules included in the asymmetric units. These complexes can feature 0, 1, or 2 bridging P-donors. These results definitively demonstrate that the P-centre of phosphane ligands can easily switch from a bridging to a semi-bridging and a non-bridging coordination mode. Dimer 2 is used as an "adaptive" molecular clip for the synthesis of pi-stacked metallocyclophanes 7 a, b and 8 upon reaction with ditopic linkers. X-ray diffraction studies revealed that these supramolecular species behave as receptors for the counteranions (PF(6), BF(4)) and that the nature of the anion impacts the stereochemistry of the supramolecular metallocyclophanes. Au(I)-Dimers 10 a, b bearing two ligands C acting as 1kappaN:2kappaP-chelates are prepared and characterised in the solid-state.

Section: Methodsmentioning

confidence: 99%

“…It is noteworthy that similar host-guest interactions between weakly coordinating anions (PF 6 À , BF 4 À ) and cationic Pd II -dimer cavities have recently been reported. [19] In these complexes, modifying the size of the anion results in major conformational changes of dipalladium complexes.…”

Section: Wwwchemeurjorgmentioning

confidence: 99%

Chemistry of Bridging Phosphanes: A Comparative Study within Cu^I‐Ag^I‐Au^I Triad‐Based Homonuclear Dimers

Welsch¹,

Nohra²,

Peresypkina³

et al. 2009

“…Despite the fact that PF 6 À is known as a weakly coordinating counterion, such coordination modes due to weak metal-fluorine interactions have been reported previously. [18,19] These results show that treating 1' with metal-based linkers exhibiting no, or at least very weak, attractive metallophilic interactions, the competitive formation of two derivatives, either a metallocyclophane or a coordination polymer, is possible.…”

Section: Notably Each Hgmentioning

confidence: 96%

Aurophilicity versus Mercurophilicity: Impact of d¹⁰–d¹⁰ Metallophilic Interactions on the Structure of Metal‐Rich Supramolecular Assemblies

Vreshch

Shen

Nohra

et al. 2011

Treatment of U-shaped, binuclear Cu(I) complexes 1,1' (1, counterion: BF(4)(-); 1', counterion: PF(6)(-)) with metal cyanide linear linkers K[Au(CN)(2)] (3) and Hg(CN)(2) (4) lead to formation of new supramolecular assemblies 5,5' and 6,6', respectively, in good yield. These derivatives have been characterized by NMR spectroscopy, IR, and X-ray diffraction studies. Derivative 5,5' are supramolecular metallacycles in which intramolecular aurophilic interactions between the Au(I) metal centers of the linkers are observed. Derivative 5 crystallizes as a single solid phase, whereas derivative 5' is characterized in the solid state as four different pseudo-polymorphs (5'a-d). Notably in the case of phase 5'd, a dimer of supramolecular metallacycles bounded by intermolecular aurophilic interactions is formed. Conversely, derivatives 6,6' present large structural diversity depending on the nature of the counterion. Derivative 6 is a supramolecular rectangle in which the Hg(II)-Hg(II) metal distance suggests mercurophilic interaction, whereas 6' crystallizes as two different pseudo-polymorphs 6'a,b, that is, a one-dimensional coordination polymer and one oligomer with no short Hg(II)-Hg(II) metal contacts, respectively. In derivatives 6,6', short contacts between the Hg(II) metal centers and fluorine atoms of the counterions are also observed, which may explain the counterion structural dependence of these supramolecular assemblies based on Hg(II) metal cyanide linker. Comparison of the different solid-state structures characterized highlights the importance of weak secondary interactions between the linkers for the formation supramolecular metallacycles from molecular clips 1,1' and suggests the range of energies required for these interactions to form metallacycles and to induce self-aggregation.

“…His research focuses on polytopic phosphorus ligands, heterometallic complexes with silicon‐containing ligands, and molecular clusters. He recently reported in Angewandte Chemie on dinuclear silver(I) and palladium(II) diphosphonite complexes that can selectively trap BF 4 − or PF 6 − ions,3b and in the European Journal of Inorganic Chemistry on mono(aryloxido)titanium(IV) complexes and their use in the dimerization of ethene 3c …”

Section: Awarded…︁mentioning

confidence: 99%

Parasite‐Based Screening and Proteome Profiling Reveal Orlistat, an FDA‐Approved Drug, as a Potential Anti Trypanosoma brucei Agent^[^]

Yang

Wang

et al. 2012

Trypanosoma brucei is a parasite that causes African sleeping sickness in humans and nagana in livestock and is transmitted by the tsetse fly. There is an urgent need for the development of new drugs against African trypanosomiasis due to the lack of vaccines and effective drugs. Orlistat (also called tetrahydrolipstatin or THL) is an FDA-approved antiobesity drug targeting primarily the pancreatic and gastric lipases within the gastrointestinal tract. It shows potential activities against tumors, mycobacteria, and parasites. Herein, we report the synthesis and evaluation of an expanded set of orlistat-like compounds, some of which showed highly potent trypanocidal activities in both the bloodstream form (BSF) and the procyclic form (PCF) of T. brucei. Subsequent in situ parasite-based proteome profiling was carried out to elucidate potential cellular targets of the drug in both forms. Some newly identified targets were further validated by the labeling of recombinantly expressed enzymes in Escherichia coli lysates. Bioimaging experiments with a selected compound were carried out to study the cellular uptake of the drug in T. brucei. Results indicated that orlistat is much more efficiently taken up by the BSF than the PCF of T. brucei and has clear effects on the morphology of mitochondria, glycosomes, and the endoplasmic reticulum in both BSF and PCF cells. These results support specific effects of orlistat on these organelles and correlate well with our in situ proteome profiling. Given the economic challenges of de novo drug development for neglected diseases, we hope that our findings will stimulate further research towards the conversion of orlistat-like compounds into new trypanocidal drugs.